Skip to main content

Combatting antimicrobial resistance in Africa through surveillance and capacity building

Thematic Series

Dr Alaa AbouElfetouh (Alexandria University, Egypt)

Most African countries are lower- or middle-income and they bear the greatest burden of antimicrobial resistance because of limited resources, insufficient lab and diagnostic capacities, poor surveillance infrastructure and staggering antimicrobial stewardship efforts and infection control plans. These handicaps negatively impact public healthcare programs. Research has the potential to make a difference through guiding public health policies and informing antimicrobial stewardship and infection control plans. Yet historically for many reasons, fewer studies on antimicrobial resistance are published from Africa. Most of these studies focus on infections in healthcare settings which are usually harder to manage. In recent years, the incidence of community associated infections has been increasing which might signify a change in the epidemiological dynamics of infection.  


To fill the knowledge gap and increase impact on public health Antimicrobial Resistance and Infection Control is launching a thematic series, entitled Combatting antimicrobial resistance in Africa through surveillance and capacity building.

In this series the journal invites researchers, particularly those from Africa but all are welcome,  to submit high quality research targeting antimicrobial resistance challenges facing the African continent in both community and hospital settings. The series covers all aspects of the fight against antimicrobial resistance, primarily surveillance, improved diagnostics, antimicrobial stewardship, infection control, education, etc. and how that would translate into national public health policies. Articles covering one or more of these aspects in a One Health approach are especially welcome.  

The series includes all manuscript types: original research articles, systematic reviews and meta-analysis articles. 

  1. Antibiotic resistance is a global concern threatening achievements in health care since the discovery of antibiotics. In Kenya, this topic remains understudied in a context of rising demand for livestock produ...

    Authors: Jeniffer Waiyego Kariuki, Jan Jacobs, Marie Paule Ngogang and Olivia Howland
    Citation: Antimicrobial Resistance & Infection Control 2023 12:3
  2. Reports are available on cross-resistance between antibiotics and biocides. We evaluated the effect of povidone-iodine (PVP-I) and propanol-based mecetronium ethyl sulphate (PBM) on resistance development, ant...

    Authors: Nada A. Barakat, Salwa A. Rasmy, Alaa El-Dien M. S. Hosny and Mona T. Kashef
    Citation: Antimicrobial Resistance & Infection Control 2022 11:139
  3. Antimicrobial resistance (AMR) in bacterial pathogens is a worldwide concern that demands immediate attention. Most information on AMR originates from high-income countries and little is known about the burden...

    Authors: Emelda E. Chukwu, Oluwatoyin B. Awoderu, Christian A. Enwuru, Ebelechukwu E. Afocha, Rahman G. Lawal, Rahaman A. Ahmed, Ishola Olanrewaju, Chika K. Onwuamah, Rosemary A. Audu and Folasade T. Ogunsola
    Citation: Antimicrobial Resistance & Infection Control 2022 11:134
  4. Antimicrobial resistance (AMR) is a major public health challenge with its impact felt disproportionately in Western Sub-Saharan Africa. Routine microbiology investigations serve as a rich source of AMR monito...

    Authors: Mavis Puopelle Dakorah, Elizabeth Agyare, Joseph Elikem Efui Acolatse, George Akafity, John Stelling, Victoria J. Chalker, Owen B. Spiller, Nana Benyin Aidoo, Frederick Kumi-Ansah, Daniel Azumah, Stephen Laryea, Robert Incoom and Eric Kofi Ngyedu
    Citation: Antimicrobial Resistance & Infection Control 2022 11:122
  5. In low- and middle-income countries, surveillance of antimicrobial resistance (AMR) is mostly hospital-based and, in view of poor access to clinical microbiology, biased to more resistant pathogens. We aimed t...

    Authors: Annelies S. Post, I. Guiraud, M. Peeters, P. Lompo, S. Ombelet, I. Karama, S. Yougbaré, Z. Garba, E. Rouamba, H. Tinto and Jan Jacobs
    Citation: Antimicrobial Resistance & Infection Control 2022 11:112
  6. Vaginal discharge syndrome (VDS) is a common condition. Clinical management targets sexually transmitted infections (STIs) and bacterial vaginosis (BV); there is limited focus on Candida infection as cause of VDS...

    Authors: Cara M. Dunaiski, Marleen M. Kock, Hyunsul Jung and Remco P. H. Peters
    Citation: Antimicrobial Resistance & Infection Control 2022 11:104
  7. Sepsis due to multidrug resistant (MDR) bacteria is a growing public health problem mainly in low-income countries.

    Authors: Melese Hailu Legese, Daniel Asrat, Göte Swedberg, Badrul Hasan, Amha Mekasha, Tadesse Getahun, Misganaw Worku, Eminet Tesfaye Shimber, Seid Getahun, Tsedale Ayalew, Birhan Gizachew, Abraham Aseffa and Adane Mihret
    Citation: Antimicrobial Resistance & Infection Control 2022 11:83
  8. Uganda remains one of the countries with the highest burden of TB/HIV. Drug-resistant TB remains a substantial challenge to TB control globally and requires new strategic effective control approaches. Drug res...

    Authors: Jupiter Marina Kabahita, Joel Kabugo, Francis Kakooza, Isa Adam, Ocung Guido, Henry Byabajungu, Joanitah Namutebi, Maria Magdalene Namaganda, Pius Lutaaya, James Otim, Fredrick Elishama Kakembo, Stephen Kanyerezi, Patricia Nabisubi, Ivan Sserwadda, George William Kasule, Hasfah Nakato…
    Citation: Antimicrobial Resistance & Infection Control 2022 11:68
  9. Blood culture diagnostics are critical tools for sepsis management and antimicrobial resistance (AMR) surveillance. A baseline study was conducted to assess reported sepsis case finding, blood culture diagnost...

    Authors: Abiodun Egwuenu, Adaora Ejikeme, Sara Tomczyk, Anja von Laer, Olaniyi Ayobami, Oluwaseun Odebajo, Samuel Akhibi, Constance Agulanna, Osayande Osagie, Ugochi Stellamaris Inweregbu, Ridwan Yahaya, Tochi Okwor, Hannah Dada-Adegbola, Ikeoluwapo Ajayi, Abdulhakeem Olorukooba, Tim Eckmanns…
    Citation: Antimicrobial Resistance & Infection Control 2022 11:65
  10. The burden of antibiotic resistant infection is mainly felt in low-to-middle income countries, where the rate of antimicrobial resistance is largely under-surveyed and under huge pressure from unregulated, dis...

    Authors: Joseph Elikem Efui Acolatse, Edward A. R. Portal, Ian Boostrom, George Akafity, Mavis Puopelle Dakroah, Victoria J. Chalker, Kirsty Sands and Owen B. Spiller
    Citation: Antimicrobial Resistance & Infection Control 2022 11:49
  11. Africa is challenged by the emergence of antimicrobial resistance (AMR). In order to improve patient management and to optimise approaches to curb the spread of antimicrobial resistance, we examined knowledge ...

    Authors: Bayode Romeo Adegbite, Jean Ronald Edoa, Frieder Schaumburg, Abraham S. Alabi, Ayola Akim Adegnika and Martin P. Grobusch
    Citation: Antimicrobial Resistance & Infection Control 2022 11:44
  12. There is limited information on surgical site infections (SSI) and the related antibiotic resistance needed to guide their management and prevention in Sierra Leone. In this study, we aimed to establish the in...

    Authors: Sulaiman Lakoh, Le Yi, Stephen Sevalie, Xuejun Guo, Olukemi Adekanmbi, Isaac O. Smalle, Nathaniel Williams, Umu Barrie, Celesis Koroma, Yongkun Zhao, Matilda N. Kamara, Constance Cummings-John, Darlinda F. Jiba, Enanga Sonia Namanaga, Betsy Deen, Juling Zhang…
    Citation: Antimicrobial Resistance & Infection Control 2022 11:39
  13. The current Coronavirus disease pandemic reveals political and structural inequities of the world’s poorest people who have little or no access to health care and yet the largest burdens of poor health. This i...

    Authors: Alicia Davis, Tiziana Lembo, Emma Laurie, Edna Mutua, Kathrin Loosli, Mary Nthambi, Amy Nimegeer, Kunda Mnzava, Elizabeth F. Msoka, Fortunata Nasuwa, Matayo Melubo, Gabriel Shirima, Louise Matthews, Shona Hilton, Stephen E. Mshana and Blandina T. Mmbaga
    Citation: Antimicrobial Resistance & Infection Control 2022 11:34
  14. Antimicrobial resistance (AMR) is a global health challenge, particularly in low- and middle-income countries where antibiotics are widely available to consumers, leading to their misuse. However, AMR educatio...

    Authors: Bernard Appiah, Lucy Asamoah-Akuoko, Elfreda Samman, Augustina Koduah, Irene Akwo Kretchy, Julius Yaw Ludu, Gloria Odonkor, Su Hyun Nam and Martha Gyansa-Luterrodt
    Citation: Antimicrobial Resistance & Infection Control 2022 11:26
  15. Lab-based surveillance (LBS) of antimicrobial resistance (AMR) is not systematically implemented in Uganda. We aimed to identify the gaps in establishing regular LBS of AMR in Uganda.

    Authors: Duku Chaplain, Butti Ben Asutaku, Muhammad Mona, Douglas Bulafu and Dickson Aruhomukama
    Citation: Antimicrobial Resistance & Infection Control 2022 11:23
  16. Infections due to extended spectrum beta-lactamase producing organisms (ESBL) have emerged as the leading cause of sepsis among hospitalized neonates in Botswana and much of sub-Saharan Africa and south Asia. ...

    Authors: Moses Vurayai, Jonathan Strysko, Kgomotso Kgomanyane, One Bayani, Margaret Mokomane, Tichaona Machiya, Tonya Arscott-Mills, David M. Goldfarb, Andrew P. Steenhoff, Carolyn McGann, Britt Nakstad, Alemayehu Gezmu, Melissa Richard-Greenblatt and Susan Coffin
    Citation: Antimicrobial Resistance & Infection Control 2022 11:14
  17. Carbapenem-resistant Enterobacterales (CRE), currently listed by the World Health Organization (WHO) as top priority critical pathogens, are a major global menace to human health. In low- and middle-income cou...

    Authors: Neveen A. Abdelaziz
    Citation: Antimicrobial Resistance & Infection Control 2022 11:13
  18. Infectious diseases are among the leading causes of death in many low-income countries, such as Ethiopia. Without reliable local data concerning causative pathogens and antimicrobial resistance, empiric treatm...

    Authors: Tafese Beyene Tufa, Colin R. Mackenzie, Hans Martin Orth, Tobias Wienemann, Tamara Nordmann, Sileshi Abdissa, Zewdu Hurissa, Andreas Schönfeld, Matthias Bosselmann, Dieter Häussinger, Klaus Pfeffer, Tom Luedde, Andre Fuchs and Torsten Feldt
    Citation: Antimicrobial Resistance & Infection Control 2022 11:8
  19. Overuse of antibiotics is a major challenge and undermines measures to control drug resistance worldwide. Postnatal women and newborns are at risk of infections and are often prescribed prophylactic antibiotic...

    Authors: Mwaka A. Kakolwa, Susannah L. Woodd, Alexander M. Aiken, Fatuma Manzi, Giorgia Gon, Wendy J. Graham and Abdunoor M. Kabanywanyi
    Citation: Antimicrobial Resistance & Infection Control 2021 10:142
  20. Antibiotic resistance is a public health concern in Democratic Republic Congo and worldwide. It is usually caused by antibiotic over prescription or dispensing practices. The consumption of animal source food ...

    Authors: Ghislain Bilamirwa Ngaruka, Brigitte Bora Neema, Theophile Kashosi Mitima, Antoine Sadiki Kishabongo and Olivier Basole Kashongwe
    Citation: Antimicrobial Resistance & Infection Control 2021 10:124
  21. Staphylococcus aureus can colonize various host species, and human-animal interaction is a significant factor for cross-species transmission. However, data on S. aureus colonization in animals, particularly on ru...

    Authors: Adebayo Osagie Shittu, Fadekemi Funmilayo Taiwo, Neele Judith Froböse, Bianca Schwartbeck, Silke Niemann, Alexander Mellmann and Frieder Schaumburg
    Citation: Antimicrobial Resistance & Infection Control 2021 10:122
  22. The development of antimicrobial resistance, which is partially attributable to the overuse and/or misuse of antibiotics in health care, is one of the greatest global public health challenges. In Sub-Saharan A...

    Authors: Sewunet Admasu Belachew, Lisa Hall and Linda A. Selvey
    Citation: Antimicrobial Resistance & Infection Control 2021 10:13